share_log

T2 Biosystems | RW: Registration Withdrawal Request

T2 Biosystems | RW: Registration Withdrawal Request

T2 Biosystems | RW：註冊提款請求
美股sec公告 ·  05/15 05:00
牛牛AI助理已提取核心訊息
T2 Biosystems, Inc., a medical diagnostic company, has formally requested the withdrawal of its Registration Statement on Form S-1, initially filed with the U.S. Securities and Exchange Commission on April 22, 2024. The company decided not to proceed with the offering that was contemplated in the Registration Statement. T2 Biosystems confirmed that no securities have been sold pursuant to the Registration Statement. The request for withdrawal was made effective immediately, as per the communication dated May 14, 2024. The company's legal counsel, Michael T. Gibbs, and representatives from Latham & Watkins LLP are handling the withdrawal process.
T2 Biosystems, Inc., a medical diagnostic company, has formally requested the withdrawal of its Registration Statement on Form S-1, initially filed with the U.S. Securities and Exchange Commission on April 22, 2024. The company decided not to proceed with the offering that was contemplated in the Registration Statement. T2 Biosystems confirmed that no securities have been sold pursuant to the Registration Statement. The request for withdrawal was made effective immediately, as per the communication dated May 14, 2024. The company's legal counsel, Michael T. Gibbs, and representatives from Latham & Watkins LLP are handling the withdrawal process.
醫療診斷公司T2 Biosystems, Inc. 已正式要求撤回其最初於2024年4月22日向美國證券交易委員會提交的S-1表格註冊聲明。該公司決定不繼續進行註冊聲明中設想的發行。T2 Biosystems證實，沒有根據註冊聲明出售任何證券。根據2024年5月14日的來文，撤回請求立即生效。該公司的法律顧問邁克爾·吉布斯和瑞生律師事務所的代表正在處理撤回程序。
醫療診斷公司T2 Biosystems, Inc. 已正式要求撤回其最初於2024年4月22日向美國證券交易委員會提交的S-1表格註冊聲明。該公司決定不繼續進行註冊聲明中設想的發行。T2 Biosystems證實，沒有根據註冊聲明出售任何證券。根據2024年5月14日的來文，撤回請求立即生效。該公司的法律顧問邁克爾·吉布斯和瑞生律師事務所的代表正在處理撤回程序。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。